Showing 111-120 of 9394 results for "".
Topical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-corticosteroids-and-topical-calcineurin-inhibitors-atopic-dermatitis/29118/Analysis of a 2024 study by Gether et al., in which the authors compared the effectiveness of topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) in adults with atopic dermatitis (AD).Staphylococcus aureus Colonization
https://practicaldermatology.com/issues/september-2025/staphylococcus-aureus-colonization/37626/In a recent review article, Piewngam and Otto examined the epidemiology, mechanisms, and clinical implications of Staphylococcus aureus (S. aureus) colonization, while evaluating both current and emerging strategies for decolonization.Mechanisms for Food Allergy Initiation by Skin Pre-disposed to Atopic Dermatitis
https://practicaldermatology.com/issues/may-june-2025/mechanisms-for-food-allergy-initiation-by-skin-pre-disposed-to-atopic-dermatitis/35922/In this research report, we highlight a 2024 study by Gao et al. investigating the mechanisms underlying food allergy initiation in neonates susceptible to atopic dermatitis (AD).Long-term Management Strategies for AD, Melasma, and More
https://practicaldermatology.com/topics/psoriasis/long-term-management-strategies-for-ad-melasma-and-more/20801/After the acute treatment phase, experts urge a long-view on management.Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuReflecting on 2016: Big Stories in Acne, Psoriasis and AD
https://practicaldermatology.com/topics/psoriasis/reflecting-on-2016-big-stories-in-acne-psoriasis-and-ad/20845/Columnists take stock of advancements over the last 12 months, with a focus on clinical implications.Protecting Your Most Valuable Asset: Insurance
https://practicaldermatology.com/topics/practice-management/protecting-your-most-valuable-asset-insurance/20817/A refresher on what you need to know about term life, permanent (cash value) life, and disability insurance.Update on Oral Contraceptive Therapy in Acne
https://practicaldermatology.com/topics/general-topics/update-on-oral-contraceptive-therapy-in-acne/21582/While OCPs can be effective against acne, it is important to understand the risks and identify ideal candidates for therapy.Effectiveness of Early Moisturizer Use in Atopic Dermatitis Prevention
https://practicaldermatology.com/issues/novemberdecember-2025/effectiveness-of-early-moisturizer-use-in-atopic-dermatitis-prevention/48889/In the 2025 study by Simpson et al entitled “Emollients to Prevent Pediatric Eczema: A Randomized Clinical Trial,” once-daily, full-body emollient use initiated at 9 weeks of age significantly reduced the cumulative incidence of atopic dermatitis (AD) by 24 months.Update On the Use of Spironolactone to Treat Adult Female Acne
https://practicaldermatology.com/topics/general-topics/update-on-the-use-of-spironolactone-to-treat-adult-female-acne/20917/There is a role for spironolactone in some adult female acne patients.